Tema Oncology Financials
| CANC Etf | 25.91 0.38 1.49% |
Net Expense Ratio 0.0075 |
Tema |
The data published in Tema Oncology's official financial statements typically reflect Tema Oncology's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Tema Oncology's quantitative information. For example, before you start analyzing numbers published by Tema accountants, it's essential to understand Tema Oncology's liquidity, profitability, and earnings quality within the context of the Health space in which it operates.
Please note, the presentation of Tema Oncology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tema Oncology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Tema Oncology's management manipulating its earnings.
Tema Oncology Etf Summary
Tema Oncology competes with Freedom Day, Franklin Templeton, IShares MSCI, Tidal Trust, and IShares Dividend. Tema Oncology is entity of United States. It is traded as Etf on NASDAQ exchange.| Instrument | USA Etf View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 87975E701 |
| Region | Global |
| Investment Issuer | Tema Global |
| Fund Category | Strategy |
| Portfolio Concentration | Theme |
| Benchmark | Dow Jones Industrial |
Tema Oncology ETF Systematic Risk
Tema Oncology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tema Oncology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Tema Oncology ETF correlated with the market. If Beta is less than 0 Tema Oncology generally moves in the opposite direction as compared to the market. If Tema Oncology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tema Oncology ETF is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tema Oncology is generally in the same direction as the market. If Beta > 1 Tema Oncology moves generally in the same direction as, but more than the movement of the benchmark.
About Tema Oncology Financials
What exactly are Tema Oncology Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Tema Oncology's income statement, its balance sheet, and the statement of cash flows. Potential Tema Oncology investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Tema Oncology investors may use each financial statement separately, they are all related. The changes in Tema Oncology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tema Oncology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Tema Oncology Thematic Clasifications
Tema Oncology ETF is part of several thematic ideas from Strategy ETFs to Theme ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasTema Oncology January 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tema Oncology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tema Oncology ETF. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tema Oncology ETF based on widely used predictive technical indicators. In general, we focus on analyzing Tema Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tema Oncology's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 5.76 | |||
| Value At Risk | (2.18) | |||
| Potential Upside | 1.43 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tema Oncology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
The market value of Tema Oncology ETF is measured differently than its book value, which is the value of Tema that is recorded on the company's balance sheet. Investors also form their own opinion of Tema Oncology's value that differs from its market value or its book value, called intrinsic value, which is Tema Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tema Oncology's market value can be influenced by many factors that don't directly affect Tema Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tema Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tema Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tema Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.